D.E. Shaw & Co’s Omega Healthcare OHI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $70.5M | Buy |
1,609,635
+901,828
| +127% | +$41.2M | 0.04% | 516 |
|
|
2025
Q4 | $31.4M | Buy |
707,807
+366,281
| +107% | +$15.8M | 0.02% | 971 |
|
|
2025
Q3 | $14.4M | Buy |
341,526
+85,617
| +33% | +$3.45M | 0.01% | 1409 |
|
|
2025
Q2 | $9.38M | Buy |
255,909
+65,831
| +35% | +$2.44M | 0.01% | 1544 |
|
|
2025
Q1 | $7.24M | Sell |
190,078
-319,047
| -63% | -$11.9M | 0.01% | 1639 |
|
|
2024
Q4 | $19.3M | Buy |
509,125
+123,689
| +32% | +$4.94M | 0.01% | 1055 |
|
|
2024
Q3 | $15.7M | Buy |
385,436
+106,085
| +38% | +$4.01M | 0.01% | 1138 |
|
|
2024
Q2 | $9.57M | Buy |
279,351
+198,621
| +246% | +$6.26M | 0.01% | 1355 |
|
|
2024
Q1 | $2.56M | Sell |
80,730
-13,649
| -14% | -$415K | ﹤0.01% | 2438 |
|
|
2023
Q4 | $2.89M | Buy |
94,379
+64,124
| +212% | +$2.06M | ﹤0.01% | 2368 |
|
|
2023
Q3 | $1M | Buy |
30,255
+8,413
| +39% | +$269K | ﹤0.01% | 3054 |
|
|
2023
Q2 | $670K | Sell |
21,842
-307
| -1% | -$8.87K | ﹤0.01% | 3291 |
|
|
2023
Q1 | $607K | Buy |
22,149
+5,602
| +34% | +$156K | ﹤0.01% | 3458 |
|
|
2022
Q4 | $462K | Sell |
16,547
-10,665
| -39% | -$322K | ﹤0.01% | 3889 |
|
|
2022
Q3 | $802K | Sell |
27,212
-152,493
| -85% | -$4.78M | ﹤0.01% | 3741 |
|
|
2022
Q2 | $5.07M | Buy |
179,705
+117,346
| +188% | +$3.34M | 0.01% | 2112 |
|
|
2022
Q1 | $1.94M | Sell |
62,359
-251,548
| -80% | -$7.42M | ﹤0.01% | 3330 |
|
|
2021
Q4 | $9.29M | Sell |
313,907
-1,149,860
| -79% | -$33.6M | 0.01% | 1726 |
|
|
2021
Q3 | $43.9M | Sell |
1,463,767
-827,466
| -36% | -$28.5M | 0.04% | 588 |
|
|
2021
Q2 | $83.1M | Buy |
2,291,233
+505,535
| +28% | +$18.8M | 0.07% | 329 |
|
|
2021
Q1 | $65.4M | Buy |
1,785,698
+964,373
| +117% | +$35.5M | 0.06% | 374 |
|
|
2020
Q4 | $29.8M | Sell |
821,325
-424,456
| -34% | -$14.4M | 0.03% | 748 |
|
|
2020
Q3 | $37.3M | Buy |
1,245,781
+136,932
| +12% | +$4.28M | 0.04% | 537 |
|
|
2020
Q2 | $33M | Buy |
1,108,849
+709,016
| +177% | +$21M | 0.04% | 532 |
|
|
2020
Q1 | $10.6M | Buy |
+399,833
| New | +$15.2M | 0.02% | 962 |
|
|
2019
Q3 | – | Sell |
-11,500
| Closed | -$448K | – | 3958 |
|
|
2019
Q2 | $423K | Sell |
11,500
-13,471
| -54% | -$491K | ﹤0.01% | 3147 |
|
|
2019
Q1 | $953K | Sell |
24,971
-368,425
| -94% | -$13.7M | ﹤0.01% | 2636 |
|
|
2018
Q4 | $13.8M | Buy |
+393,396
| New | +$13.6M | 0.02% | 898 |
|
|
2018
Q1 | – | Sell |
-63,735
| Closed | -$1.75M | – | 3706 |
|
|
2017
Q4 | $1.75M | Sell |
63,735
-42,691
| -40% | -$1.23M | ﹤0.01% | 2230 |
|
|
2017
Q3 | $3.4M | Sell |
106,426
-117,297
| -52% | -$3.76M | 0.01% | 1668 |
|
|
2017
Q2 | $7.39M | Sell |
223,723
-686,508
| -75% | -$22.7M | 0.01% | 1071 |
|
|
2017
Q1 | $30M | Sell |
910,231
-377,172
| -29% | -$12.1M | 0.05% | 427 |
|
|
2016
Q4 | $40.2M | Buy |
1,287,403
+1,278,097
| +13,734% | +$39.4M | 0.07% | 371 |
|
|
2016
Q3 | $330K | Sell |
9,306
-246,494
| -96% | -$8.76M | ﹤0.01% | 3005 |
|
|
2016
Q2 | $8.68M | Sell |
255,800
-211,080
| -45% | -$7.04M | 0.02% | 963 |
|
|
2016
Q1 | $16.5M | Buy |
466,880
+458,496
| +5,469% | +$15M | 0.03% | 624 |
|
|
2015
Q4 | $293K | Sell |
8,384
-8,000
| -49% | -$276K | ﹤0.01% | 3374 |
|
|
2015
Q3 | $576K | Buy |
+16,384
| New | +$575K | ﹤0.01% | 2968 |
|
|
2014
Q1 | – | Sell |
-17,207
| Closed | -$513K | – | 4516 |
|
|
2013
Q4 | $513K | Sell |
17,207
-38,909
| -69% | -$1.23M | ﹤0.01% | 3715 |
|
|
2013
Q3 | $1.68M | Sell |
56,116
-9,119
| -14% | -$277K | ﹤0.01% | 2578 |
|
|
2013
Q2 | $2.02M | Buy |
+65,235
| New | +$2.14M | ﹤0.01% | 2104 |
|
Other funds holding OHI
VPM
VCM
D.E. Shaw & Co's OHI Position: Q1 2026 in Review
D.E. Shaw & Co increased its Omega Healthcare (OHI) stake by 127% in Q1 2026, buying an estimated $41.2M and bringing the position to 1,609,635 shares worth $70.5M. The position accounts for 0.04% of the portfolio, ranked #516.
D.E. Shaw & Co first reported a position in OHI in Q2 2013 and has held it in 41 quarters since. The position peaked at $83.1M in Q2 2021. 740 funds tracked by Wall St. Rank hold OHI as of Q1 2026.
- D.E. Shaw & Co held 1,609,635 shares of Omega Healthcare worth $70.5M as of Q1 2026.
- D.E. Shaw & Co bought 901,828 Omega Healthcare shares in Q1 2026, an estimated $41.2M.
- Omega Healthcare made up 0.04% of D.E. Shaw & Co's portfolio in Q1 2026, its #516 holding.
- D.E. Shaw & Co first reported a position in Omega Healthcare in Q2 2013 and has held it in 41 quarters since.
- D.E. Shaw & Co's Omega Healthcare position peaked at $83.1M in Q2 2021.
- 740 funds tracked by Wall St. Rank held Omega Healthcare as of Q1 2026.
Based on D.E. Shaw & Co's 13F filing for Q1 2026, filed 15 May 2026.